You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Details for Patent: 3,660,577


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,660,577
Title:N-trityl-imidazoles as antifungal agents
Abstract:N-TRITYL-IMIDAZOLES AND SALTS THEREOF OF THE FORMULA: 1-((((X)N-PHENYL),((X'')N-PHENYL),((X")N-PHENYL)-)C-),2-R, WHEREIN R, R1 AND R2 ARE HYDROGEN, LOWER ALKYL OR PHENYL, OR R1 AND R2 TOGETHER FORM AN ANELLATED BENZENE RING, X, X'' AND X" ARE ALKYL OF 1 TO 12 CARBON ATOMS OR AN ELECTRO-NEGATIVE MOIETY, AND N, N'' AND N" ARE AN INTEGER FROM 0 TO 2, OR PHARMACEUTICALLY ACCEPTABLE ACID SALTS THEREOF MAY BE PRODUCED BY REACTING A SILVER SALT OR ALKALI METAL SALT OF AN IMIDAZOLE OF THE FORMULA: 2-R,4-R1,5-R2-IMIDAZOLE WITH A TRITYL HALIDE OF THE FORMULA: (((X)N-PHENYL),((X'')N-PHENYL),((X")N-PHENYL)-)C-HAL 4-R1,5-R2-IMIDAZOLE WHEREIN THE SUBSTITUENTS ARE AS ABOVE DEFINED AND HAL IS HALOGEN. THESE COMPOUNDS ARE USEFUL AS ANTIMYCOTICS.
Inventor(s):Karl-Heinz Buchel, Erich Regel, Manfred Plompel
Assignee:Bayer AG
Application Number:US758594A
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of U.S. Patent 3,660,577: A Detailed Examination

Introduction

U.S. Patent 3,660,577, though an older patent, provides a fascinating case study for understanding the evolution of patent law, the scope of patent claims, and the broader patent landscape. This analysis will delve into the specifics of this patent, its claims, and the context in which it was granted.

Background of U.S. Patent 3,660,577

To begin, it is essential to identify the patent in question. However, since the specific details of U.S. Patent 3,660,577 are not provided in the sources, we will need to rely on general principles of patent analysis.

Understanding Patent Claims

Patent claims are the heart of any patent, defining the scope of the invention and what is protected by the patent. Here are some key points to consider:

Claim Language and Scope

The scope of a patent is often measured by metrics such as independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process than broader claims[3].

Claim Construction

The construction of claims is crucial in determining the scope of protection. Courts often engage in claim construction to clarify ambiguous terms, as seen in cases like DDR Holdings, LLC v. Priceline.com LLC, where the court had to interpret terms like "merchants" and "commerce object" to determine infringement[2].

Patent Landscape in the 1970s

U.S. Patent 3,660,577 was granted in the 1970s, a period marked by significant technological advancements and changes in the patent landscape.

Technological Trends

During the 1970s, technological areas such as electrical engineering, mechanical engineering, and chemistry were prominent. Patents in these fields were on the rise, reflecting the innovative activities of the time. For example, electrical engineering patents more than doubled between 2000 and 2018, but this trend was already evident in earlier decades[1].

Patenting by Industries

The 1970s saw significant patenting activity from various industries, including computer and electronics manufacturing. These industries were at the forefront of innovation, with firms in these sectors receiving a substantial number of patents. This trend continues to the present day, with high R&D industries having high rates of patenting[1].

Global Patent Trends

While U.S. Patent 3,660,577 is a domestic patent, understanding global patent trends provides context.

International Patent Families

The number of international patent families has increased significantly over the years. For instance, China saw an eightfold increase in international patent families from 2008 to 2018, highlighting the growing global importance of intellectual property[1].

Global Dossier

Modern tools like the Global Dossier, which provides access to file histories of related applications from participating IP Offices, have streamlined the process of managing global patent portfolios. This was not available during the time U.S. Patent 3,660,577 was granted, but it underscores the evolving nature of patent management[4].

Public Access to Patent Information

The U.S. Patent and Trademark Office (USPTO) has always been a key resource for accessing patent information.

USPTO Public Search Facility

The USPTO Public Search Facility, located in Alexandria, VA, provides public access to patent and trademark information. This facility, while not as advanced as today's online tools, was crucial for researchers and inventors during the 1970s[4].

Key Takeaways

  • Patent Claims: The scope and clarity of patent claims are critical in defining the invention and determining its validity.
  • Technological Trends: The 1970s were marked by significant advancements in electrical, mechanical, and chemical engineering, which are reflected in patent trends.
  • Industry Patenting: Industries with high R&D investments tend to have higher rates of patenting.
  • Global Patent Landscape: The global patent landscape has evolved significantly, with tools like the Global Dossier facilitating international patent management.
  • Public Access: Public access to patent information has been a cornerstone of the USPTO's mission, aiding in innovation and transparency.

FAQs

  1. What are the key metrics for measuring patent scope?

    • Independent claim length and independent claim count are simple yet effective metrics for measuring patent scope[3].
  2. How has the global patent landscape changed over the years?

    • The global patent landscape has seen significant increases in international patent families, particularly from countries like China. Tools like the Global Dossier have also streamlined global patent management[1][4].
  3. What is the role of the USPTO in granting patents?

    • The USPTO is the agency responsible for granting U.S. patents and registering trademarks. It also provides public access to patent and trademark information[5].
  4. How important is claim construction in patent litigation?

    • Claim construction is crucial in determining the scope of protection and resolving infringement disputes, as seen in cases like DDR Holdings, LLC v. Priceline.com LLC[2].
  5. What industries have historically been high patent filers?

    • Industries such as computer and electronics manufacturing, and scientific R&D services have been among the highest patent filers, reflecting their high R&D investments[1].

Sources

  1. National Center for Science and Engineering Statistics, National Science Foundation. Invention: U.S. and Comparative Global Trends.
  2. United States Court of Appeals for the Federal Circuit. DDR Holdings, LLC v. Priceline.com LLC.
  3. SSRN. Patent Claims and Patent Scope.
  4. United States Patent and Trademark Office. Search for patents.
  5. USA.gov. U.S. Patent and Trademark Office (USPTO).

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 3,660,577

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 3,660,577

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Austria 278001 ⤷  Try for Free
Austria 285600 ⤷  Try for Free
Belgium 720801 ⤷  Try for Free
Belgium 721378 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.